Cargando…

MALAT1 silencing suppresses prostate cancer progression by upregulating miR-1 and downregulating KRAS

BACKGROUND: Prostate cancer (PC) is the second leading cause of cancer-related deaths among men. Long noncoding RNA metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) performed as an oncogene in multiple cancers including PC. However, the molecular mechanisms of MALAT1 implicated in PC...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Junkai, Xu, Weibo, Du, Xinyi, Hou, Junqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007192/
https://www.ncbi.nlm.nih.gov/pubmed/29942138
http://dx.doi.org/10.2147/OTT.S164131
_version_ 1783332988546711552
author Chang, Junkai
Xu, Weibo
Du, Xinyi
Hou, Junqing
author_facet Chang, Junkai
Xu, Weibo
Du, Xinyi
Hou, Junqing
author_sort Chang, Junkai
collection PubMed
description BACKGROUND: Prostate cancer (PC) is the second leading cause of cancer-related deaths among men. Long noncoding RNA metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) performed as an oncogene in multiple cancers including PC. However, the molecular mechanisms of MALAT1 implicated in PC progression have not been thoroughly elaborated. MATERIALS AND METHODS: Reverse transcription-quantitative polymerase chain reaction assay was used to detect the expressions of MALAT1 and microRNA-1 (miR-1). Protein levels of cleaved poly (ADP-ribose) polymerase, cleaved caspase-3, BAX, bcl-2, and KRAS were determined using a western blot assay. Cell proliferation was assessed by colony formation and MTS assays. Cell migration capacity was examined by transwell migration assay (Corning Incorporated, Corning, NY, USA). Apoptosis rate was measured by flow cytometry via double staining of annexin V-FITC and propidium iodide. Luciferase and RNA immunoprecipitation assays were employed to explore the relationship among miR-1, MALAT1, and KRAS. RESULTS: MALAT1 expression was upregulated and miR-1 expression was downregulated in PC tissues and cell lines. MALAT1 knockdown inhibited cell proliferation and migration, and promoted cell apoptosis in androgen receptor-negative DU145 and PC3 cells. Molecular mechanism explorations disclosed that MALAT1 acted as a molecular sponge of miR-1 in DU145 cells. Moreover, miR-1 downregulation partly abrogated MALAT1 silencing-mediated anti-proliferative, antimigratory, and proapoptotic effects in DU145 and PC3 cells. Further investigation revealed that KRAS was a target of miR-1 in DU145 cells. MALAT1 acted as a competing endogenous RNA of miR-1, resulting in the increase of KRAS expression in DU145 and PC3 cells. Furthermore, miR-1 overexpression hampered proliferation and migration and promoted apoptosis in DU145 and PC3 cells, while these effects were markedly weakened following KRAS upregulation. CONCLUSION: MALAT1 knockdown inhibited proliferation and migration and facilitated apoptosis by upregulating miR-1 and downregulating KRAS in androgen receptor-negative PCa cells, providing a new insight into the molecular basis of MALAT1 and a potential biomarker or therapeutic target for suppressing castration-resistant PC.
format Online
Article
Text
id pubmed-6007192
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-60071922018-06-25 MALAT1 silencing suppresses prostate cancer progression by upregulating miR-1 and downregulating KRAS Chang, Junkai Xu, Weibo Du, Xinyi Hou, Junqing Onco Targets Ther Original Research BACKGROUND: Prostate cancer (PC) is the second leading cause of cancer-related deaths among men. Long noncoding RNA metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) performed as an oncogene in multiple cancers including PC. However, the molecular mechanisms of MALAT1 implicated in PC progression have not been thoroughly elaborated. MATERIALS AND METHODS: Reverse transcription-quantitative polymerase chain reaction assay was used to detect the expressions of MALAT1 and microRNA-1 (miR-1). Protein levels of cleaved poly (ADP-ribose) polymerase, cleaved caspase-3, BAX, bcl-2, and KRAS were determined using a western blot assay. Cell proliferation was assessed by colony formation and MTS assays. Cell migration capacity was examined by transwell migration assay (Corning Incorporated, Corning, NY, USA). Apoptosis rate was measured by flow cytometry via double staining of annexin V-FITC and propidium iodide. Luciferase and RNA immunoprecipitation assays were employed to explore the relationship among miR-1, MALAT1, and KRAS. RESULTS: MALAT1 expression was upregulated and miR-1 expression was downregulated in PC tissues and cell lines. MALAT1 knockdown inhibited cell proliferation and migration, and promoted cell apoptosis in androgen receptor-negative DU145 and PC3 cells. Molecular mechanism explorations disclosed that MALAT1 acted as a molecular sponge of miR-1 in DU145 cells. Moreover, miR-1 downregulation partly abrogated MALAT1 silencing-mediated anti-proliferative, antimigratory, and proapoptotic effects in DU145 and PC3 cells. Further investigation revealed that KRAS was a target of miR-1 in DU145 cells. MALAT1 acted as a competing endogenous RNA of miR-1, resulting in the increase of KRAS expression in DU145 and PC3 cells. Furthermore, miR-1 overexpression hampered proliferation and migration and promoted apoptosis in DU145 and PC3 cells, while these effects were markedly weakened following KRAS upregulation. CONCLUSION: MALAT1 knockdown inhibited proliferation and migration and facilitated apoptosis by upregulating miR-1 and downregulating KRAS in androgen receptor-negative PCa cells, providing a new insight into the molecular basis of MALAT1 and a potential biomarker or therapeutic target for suppressing castration-resistant PC. Dove Medical Press 2018-06-15 /pmc/articles/PMC6007192/ /pubmed/29942138 http://dx.doi.org/10.2147/OTT.S164131 Text en © 2018 Chang et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Chang, Junkai
Xu, Weibo
Du, Xinyi
Hou, Junqing
MALAT1 silencing suppresses prostate cancer progression by upregulating miR-1 and downregulating KRAS
title MALAT1 silencing suppresses prostate cancer progression by upregulating miR-1 and downregulating KRAS
title_full MALAT1 silencing suppresses prostate cancer progression by upregulating miR-1 and downregulating KRAS
title_fullStr MALAT1 silencing suppresses prostate cancer progression by upregulating miR-1 and downregulating KRAS
title_full_unstemmed MALAT1 silencing suppresses prostate cancer progression by upregulating miR-1 and downregulating KRAS
title_short MALAT1 silencing suppresses prostate cancer progression by upregulating miR-1 and downregulating KRAS
title_sort malat1 silencing suppresses prostate cancer progression by upregulating mir-1 and downregulating kras
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007192/
https://www.ncbi.nlm.nih.gov/pubmed/29942138
http://dx.doi.org/10.2147/OTT.S164131
work_keys_str_mv AT changjunkai malat1silencingsuppressesprostatecancerprogressionbyupregulatingmir1anddownregulatingkras
AT xuweibo malat1silencingsuppressesprostatecancerprogressionbyupregulatingmir1anddownregulatingkras
AT duxinyi malat1silencingsuppressesprostatecancerprogressionbyupregulatingmir1anddownregulatingkras
AT houjunqing malat1silencingsuppressesprostatecancerprogressionbyupregulatingmir1anddownregulatingkras